Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
Clinical trial NCT00072319 · COMPLETED
Trial details
- NCT number
- NCT00072319
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Primary completion
- 2006-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.